Multimorbidity and depression treatment

General Hospital Psychiatry

Volumn 33, Issue 3, 2011, Pages 238-245

  Vyas, Ami ^a   Sambamoorthi, Usha ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Depression; Medical Expenditure Panel Survey; Multimorbidity; Psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTHRITIS; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OSTEOPOROSIS; OUTPATIENT CARE; PSYCHOTHERAPY; SOCIOECONOMICS; STATISTICAL MODEL;

ADULT; AGED; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 79956123819     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2011.02.009     Document Type: Article

References (48)

1. Van den Akker M., Buntinx F., Metsemakers J.R., Roos S., Knottnersus J. Multimorbidity in general practice: prevalence, incidence and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998, 51:367-375.
2. Fortin M., Brave G., Hudon C., Vanasse A., Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 2005, 3(3):223-228.
3. Schneider K.M., O'Donnell B.E., Dean D. Prevalence of multiple chronic conditions in the United States Medicare population. Health Qual Life Outcomes 2009, 7:82.
4. Noël P.H., Parchman M.L., Williams J.W., Cornell J.E., Shuko L., Zeber J.E., et al. The challenges of multimorbidity from the patient perspective. J Gen Intern Med 2007, 22(3):419-424.
5. Fortin M., Lapointe L., Hudon C., Vanasse A., Ntetu A.L., Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes 2004, 2:51.
6. Condelius A., Edberg A.K., Jakobsson U., Hallberg I.R. Hospital admissions among people 65+ related to multimorbidity, municipal and outpatient care. Arch Gerontol Geriatr 2008, 46(1):41-55.
7. Marengoni A., von Strauss E., Rizzuto D., Winblad B., Fratiglioni L. The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med 2009, 265(2):288-295.
8. Lee T.A., Shields A.E., Vogeli C., Gibson T.B., Woong-Sohn M., Marder W.D., et al. Mortality rate in veterans with multiple chronic conditions. J Gen Intern Med 2007, 22(3):403-407.
9. Wolff J.L., Starfield B., Anderson G. Prevalence, expenditures and complications of multiple chronic conditions in elderly. Arch Intern Med 2002, 162:2269-2276.
10. Kent L.K., Shapiro P.A. Depression and related psychological factors in heart disease. Harv Rev Psychiatry 2009, 17(6):377-388.
11. Scalco A.Z., Scalco M.Z., Azul J.B., Lotufo Neto F. Hypertension and depression. Clinics (Sao Paulo) 2005, 60(3):241-250.
12. Ali S., Stone M.A., Peters J.L., Davies M.J., Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006, 23:1165-1173.
13. Barnard K.D., Skinner T.C., Peveler R. The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabet Med 2006, 23:445-448.
14. Mikkelsen R.L., Middelboe T., Pisinger C., Stage K.B. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004, 58:65-70.
15. Opolski M., Wilson I. Asthma and depression: a pragmatic review of the literature and recommendations for future research. Clin Pract Epidemiol Ment Health 2005, 1:18.
16. Dickens C., McGowan L., Clark-Carter D., Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002, 64:52-60.
17. Cizza G., Primma S., Coyle M., Gourgiotis L., Csako G. Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res 2010, 42(7):467-482.
18. Fortin M., Bravo G., Hudon C., Lapointe L., Dubois M.F., Almirall J. Psychological distress and multimorbidity in primary care. Ann Fam Med 2006, 4(5):417-422.
19. Goldstein G., Luther J.F., Haas G.L., Gordon A.J., Appelt C. Comorbidity between psychiatric and general medical disorders in homeless veterans. Psychiatr Q 2009, 80:199-212.
20. Petrak F., Herpertz S. Treatment of depression in diabetes: an update. Curr Opin Psychiatry 2009, 22(2):211-217.
21. Joynt K.E., O'Connor C.M. Lessons from SADHART, ENRICHD, and other trials. Psychosom Med 2005, 67(1):S63-S66.
22. Katon W.J., Lin E.H., Korff M.V., Ciechanowski P., Ludman E.J., Young B., et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010, 363:2611-2620.
23. Nutting P.A., Rost K., Smith J., Werner J.J., Elliot C. Competing demands from physical problems. Effect on initiating and completing depression care over 6 months. Arch Fam Med 2000, 9:1059-1064.
24. Rost K., Nutting P., Smith J., Coyne J.C., Cooper-Patrick L., Rubinstein L. The role of competing demands in the treatment provided to primary care patients with major depression. Arch Fam Med 2000, 9:150-154.
25. Ereshefsky L., Jhee S., Grothe D. Antidepressant drug-drug profile update. Drugs R D 2005, 6(6):323-336.
26. Atlantis E., Browning C., Sims J., Kendig H. Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). Int J Geriatr Psychiatry 2010, 25(7):688-696.
27. Andersohn F., Schade R., Suissa S., Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 2009, 166(5):591-598.
28. Min L.C., Wenger L.S., Fung C., Chang J.T., Ganz D.A., Higashi T., et al. Multimorbidity is associated with better quality of care among vulnerable elders. Med Care 2007, 45(6):480-488.
29. Dickinson L.M., Dickinson W.P., Rost K., deGruy F., Emsermann C., Froshaug D., et al. Clinician burden and depression treatment: disentangling patient- and clinician-level effects of medical comorbidity. J Gen Intern Med 2008, 23(11):1763-1769.
30. Harman J.S., Edlund M.J., Fortney J.C., Kallas H. The influence of comorbid chronic medical conditions on the adequacy of depression care for older Americans. J Am Geriatr Soc 2005, 53(12):2178-2183.
31. Medical Expenditure Panel Survey (MEPS) 2007, Accessed on February 17, 2011. http://www.meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h113/h113doc.pdf.
32. Roehrig C., Miller G., Lake C., Bryant J. National health spending by medical condition, 1996-2005. Health Aff (Millwood) 2009, 28(2):358-367.
33. Fortin M., Dubois M.F., Hudon C., Soubhi H., Almirall J. Multimorbidity and quality of life: a closer look. Health Qual Life Outcomes 2007, 5:52.
34. Meduru P., Helmer D., Rajan M., Tseng C.L., Pogach L., Sambamoorthi U. Chronic illness with complexity: implications for performance measurement of optimal glycemic control. J Gen Intern Med 2007, 22(3):408-418.
35. Harpole L.H., Williams J.W., Olsen M.K., Stechuchak K.M., Oddone E., Callahan C.M., et al. Improving depression outcomes in older adults with comorbid medical illness. Gen Hosp Psychiatry 2005, 27(1):4-12.
36. Ani C., Bazargan M., Hindman D., Bell D., Rodriguez M., Baker R.S. Comorbid chronic illness and the diagnosis and treatment of depression in safety net primary care setting. J Am Board Fam Med 2009, 22:123-135.
37. Koike A.K., Unutzer J., Well K.B. Improving the care for depression in patients with comorbid medical illness. Am J Psychiatry 2002, 159:1738-1745.
38. Lagu T., Weiner M.G., Hollenbeak C.S., Eachus S., Roberts C.S., Schwartz J.S., et al. The impact of concordant and discordant conditions on the quality of care for hyperlipidemia. J Gen Intern Med 2008, 23(8):1208-1213.
39. Lustman P.J., Griffith L.S., Clouse R.E., Freedland K.E., Eisen S.A., Rubin E.H., et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997, 59:241-250.
40. Paile-Hyvarinen M., Wahlbeck K., Eriksson J. Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial. BMC Fam Pract 2007, 8:34.
41. Iosifescu D.V., Bankier B., Fava M. Impact of medical comorbid disease on antidepressant treatment of major depressive disorder. Curr Psychiatry Rep 2004, 6:193-201.
42. Sarzi Puttini P., Cazzola M., Boccassini L., Ciniselli G., Santandrea S., Caruso I., et al. A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depression. J Intern Med Res 1988, 16(5):331-337.
43. Fournier J.C., DeRubeis R.J., Hollen S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010, 303(1):47-53.
44. Shin N.M., Hagerty B., Williams R. Gender comparisons in depressive symptoms and use of antidepressant medications after acute coronary syndrome. Appl Nurs Res 2010, 23(2):73-79.
45. Tiwari A., Rajan M., Miller D., Pogach L., Olfson M., Sambamoorthi U. Guideline-consistent antidepressant treatment patterns among veterans with diabetes and major depressive disorder. Psychiatr Serv 2008, 59(10):1139-1147.
46. Simpson S.M., Krishnan L.L., Kunik M.E., Ruiz P. Racial disparities in diagnosis and treatment of depression: a literature review. Psychiatr Q 2007, 78(1):3-14.
47. Smith J.L., Rost K.M., Nutting P.A., Elliott C.E. Resolving disparities in antidepressant treatment and quality-of-life outcomes between uninsured and insured primary care patients with depression. Med Care 2001, 39(9):910-922.
48. Kashner T.M., Trivedi M.H., Wicker A., Fava M., Wisniewski S.R., Rush A.J. The impact of nonclinical factors on care use for patients with depression: a STAR*D report. CNS Neurosci Ther 2009, 15(4):320-332.